AbbVie files lawsuit over selection of Botox for Medicare price negotiations
Source: SeekingAlpha
2026-02-12 14:35:11 ET
More on AbbVie
- AbbVie: The Market Is Getting It Wrong
- AbbVie: Skyrizi And Rinvoq Growth Isn't Everything, But It's A Lot
- AbbVie: Double-Digit Growth For Immunology Products Continues With HUMIRA Surprise
- Earnings Scorecard: 22 out of 23 healthcare firms deliver EPS wins this week
- AbbVie forecasts 9.5% sales growth in 2026 amid blockbuster launches and pipeline momentum
Read the full article on Seeking Alpha
For further details see:
AbbVie files lawsuit over selection of Botox for Medicare price negotiations
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
-0.97% G/L:
$224.48 Last:
1,406,476 Volume:
$226.89 Open:
ABBV Latest News
March 13, 2026 01:36:56 pm
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
